Literature DB >> 7298073

Non-immunological recognition and killing of xenogeneic cells by macrophages. II. Mechanism of killing.

S Cabilly, R Gallily.   

Abstract

Macrophages are cytotoxic to chicken embryonic fibroblasts without either previous activation or lymphocyte assistance. This cytotoxic activity (xenolysis) is expressed by non-activated macrophages from athymic mice as well as by pure macrophage populations. Neither macrophage lysate nor supernatants of macrophages cultivated with fibroblasts cause xenolysis. Unlike macrophage tumoricidal activity, killing of xenogeneic cells is not dependent on specific serum factors and is expressed by macrophages from a lipopolysaccharide (LPS) unresponsive strain (C3H/HeJ). Xenolysis is expressed also by trypsin-treated macrophages and by macrophages from 5-day-old cultures. Killing of chicken fibroblasts by macrophages is not affected by hydrocortisone (100 micrograms/ml) gold salt (1 mg/ml) and colchicine (100 micrograms/ml). On the other hand, cytochalasin B (10 micrograms/ml) completely abolishes the killing, probably by interfering with macrophage mobility and extension of filopodia toward the targets. It is suggested that the xenolytic activity of macrophages represents a primitive trait of phagocytes which assists the body in defence against multicellular parasites.

Entities:  

Mesh:

Year:  1981        PMID: 7298073      PMCID: PMC1555217     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  20 in total

1.  [Cyst of the thymus gland].

Authors:  G L VOL'-EPSHTEIN
Journal:  Grudn Khir       Date:  1962 May-Jun

2.  Recognition factors of the crayfish and the generation of diversity.

Authors:  C R Jenkin; D Hardy
Journal:  Adv Exp Med Biol       Date:  1975       Impact factor: 2.622

3.  Tumor cell killing by macrophages activated in vitro with lymphocyte mediators. III. Inhibition by cytochalasins, colchicine, and vinblastine.

Authors:  S D Sharma; W F Piessens
Journal:  Cell Immunol       Date:  1978-07       Impact factor: 4.868

4.  Macrophage tumor killing: influence of the local environment.

Authors:  J B Hibbs; R R Taintor; H A Chapman; J B Weinberg
Journal:  Science       Date:  1977-07-15       Impact factor: 47.728

5.  Heterocytolysis by macrophages activated by bacillus Calmette-Guérin: lysosome exocytosis into tumor cells.

Authors:  J B Hibbs
Journal:  Science       Date:  1974-04-26       Impact factor: 47.728

6.  Mechanisms of target cell destruction by alloimmune peritoneal macrophages. II. Release of a specific cytotoxin from interacting cells.

Authors:  K L McIvor; R S Weiser
Journal:  Immunology       Date:  1971-03       Impact factor: 7.397

Review 7.  Macrophage activation by lymphocyte mediators.

Authors:  J R David
Journal:  Fed Proc       Date:  1975-07

8.  Macrophage activation for tumor cytotoxicity: control of macrophage tumoricidal capacity by the LPS gene.

Authors:  L P Ruco; M S Meltzer; D L Rosenstreich
Journal:  J Immunol       Date:  1978-08       Impact factor: 5.422

9.  Morphological evidence for the translocation of lysosomal organelles from cytotoxic macrophages into the cytoplasm of tumor target cells.

Authors:  C Bucana; L C Hoyer; B Hobbs; S Breesman; M McDaniel; M G Hanna
Journal:  Cancer Res       Date:  1976-12       Impact factor: 12.701

10.  Extracellular cytolysis by activated macrophages and granulocytes. I. Pharmacologic triggering of effector cells and the release of hydrogen peroxide.

Authors:  C F Nathan; L H Brukner; S C Silverstein; Z A Cohn
Journal:  J Exp Med       Date:  1979-01-01       Impact factor: 14.307

View more
  2 in total

1.  Recognition and lysis of altered-self cells by macrophages. I. Modification of target cells by 2,4,6-trinitrobenzene sulphonic acid.

Authors:  S Kunin; R Gallily
Journal:  Immunology       Date:  1983-02       Impact factor: 7.397

2.  Influence of osteogenic stimulation and VEGF treatment on in vivo bone formation in hMSC-seeded cancellous bone scaffolds.

Authors:  Ulrich Lenze; Florian Pohlig; Sebastian Seitz; Christina Ern; Stefan Milz; Denitsa Docheva; Matthias Schieker
Journal:  BMC Musculoskelet Disord       Date:  2014-10-16       Impact factor: 2.362

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.